About FDA

Description: In support of the FDASIA Section 907 Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data, OWH is conducting digital and traditional outreach activities to raise awareness of the importance of the participation of diverse women in clinical trials and to share best practices about clinicial research design, recruitment, and subpopulation analyses.

Accomplishment: OWH collaborated with other FDA partners and external organizations to raise awareness about the participation of diverse women in clinical trials. OWH launched the Diverse Women in Clinical Trials Awareness Campaign in January 2016 with a social media rally of 260 supporters reaching 2.7 million. The campaign distributed nearly 69,000 fact sheets and posters in English and Spanish in FY16 and disseminated over 500 partner toolkits to help increase traffic to the women in clinical trials webpage. OWH conducted digital outreach including ad campaigns, social media promotions and a Twitter chat with FDA’s Office of Minority Health. OWH also launched a new women in clinical trials webpage: www.fda.gov/womeninclinicaltrials. Lastly, OWH partnered with the Association of Clinical Research Professionals to develop a series of webinars that will be held in November 2016.